O
Ola Samuelsson
Researcher at University of Gothenburg
Publications - 4
Citations - 1973
Ola Samuelsson is an academic researcher from University of Gothenburg. The author has contributed to research in topics: Blood pressure & Renal function. The author has an hindex of 4, co-authored 4 publications receiving 1830 citations.
Papers
More filters
Journal ArticleDOI
Rosuvastatin and cardiovascular events in patients undergoing hemodialysis
Bengt Fellström,Alan G. Jardine,Roland E. Schmieder,Hallvard Holdaas,Kym M. Bannister,J.J. Beutler,Dong Wan Chae,Alejandro Chevaile,Stuart M. Cobbe,Carola Grönhagen-Riska,José Jayme Galvão de Lima,Robert L. Lins,Gert Mayer,Alan W. McMahon,Hans-Henrik Parving,Hans-Henrik Parving,Giuseppe Remuzzi,Ola Samuelsson,Sandor Sonkodi,Gultekin Suleymanlar,Dimitrios Tsakiris,Vladimir Tesar,Vasil Todorov,Andrzej Wiecek,Rudolf P. Wüthrich,Mattis Gottlow,Eva Johnsson,Faiez Zannad +27 more
TL;DR: In patients undergoing hemodialysis, the initiation of treatment with rosuvastatin lowered the LDL cholesterol level but had no significant effect on the composite primary end point of death from cardiovascular causes, nonf fatal myocardial infarction, or nonfatal stroke.
Journal ArticleDOI
The J-shaped relationship between coronary heart disease and achieved blood pressure level in treated hypertension: further analyses of 12 years of follow-up of treated hypertensives in the Primary Prevention Trial in Gothenburg, Sweden.
TL;DR: The relationship between the blood pressure level achieved through antihypertensive treatment and the incidence of coronary heart disease was studied in middle-aged hypertensive men, indicating that an excessive lowering of blood pressure in hypertensive patients may be harmful.
Journal ArticleDOI
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Jalal K. Ghali,John Wikstrand,Dirk J. van Veldhuisen,Björn Fagerberg,Sidney Goldstein,Åke Hjalmarson,Peter A. Johansson,John Kjekshus,Lis Ohlsson,Ola Samuelsson,Finn Waagstein,Hans Wedel +11 more
TL;DR: Renal function as estimated by eGFR was a powerful predictor of death and hospitalizations from worsening HF and metoprolol CR/XL was at least as effective in reducing death andospitalizations for worsening HF in patients with eG FR < 45 as in those with e GFR > 60.
Journal Article
Prognostic factors in treated hypertension.
TL;DR: The findings show that in spite of treatment for hypertension, the CVD risk is still substantial if organ damage or other risk factors are present, and underline the importance of multiple risk factor intervention in hypertensive patients.